{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Whitehawk Therapeutics, Inc."},"Symbol":{"label":"Symbol","value":"WHWK"},"Address":{"label":"Address","value":"2 HEADQUARTERS PLAZA EAST BUILDING,11TH FLOOR, MORRISTOWN, New Jersey, 90272, United States"},"Phone":{"label":"Phone","value":"+1 (551) 321-2234"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Whitehawk Therapeutics is a preclinical stage oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved cancer treatments. Whitehawk's advanced three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers. These assets are in-licensed from WuXi Biologics under an exclusive development and global commercialization agreement."},"CompanyUrl":{"label":"Company Url","value":"https://www.whitehawktx.com"}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}